Igor Stukalin

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors

Sarah Cook, Vanessa Samuel, Daniel E. Meyers et al. · JAMA Network Open · 2024 · 152 citations · Full text

Life Sciences, Immunology, Oncology +16

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

J. Connor Wells, Igor Stukalin, Craig Norton et al. · European Urology · 2016 · 88 citations · Full text

Medicine, Nephrology, Oncology +14

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

Daniel E. Meyers, Igor Stukalin, Isabelle A. Vallerand et al. · Cancers · 2019 · 76 citations · Full text

Medicine, Immunology, Oncology +17

Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

Alexander Watson, Siddhartha Goutam, Igor Stukalin et al. · JAMA Network Open · 2022 · 65 citations · Full text

Life Sciences, Immunology, Oncology +15

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996–2016

Christopher Ma, Alexander S. Qian, Nghia Nguyen et al. · The American Journal of Gastroenterology · 2021 · 64 citations

Public Affairs, Health Policy, Health Economics +16